Remoxipride hydrochloride

Discontinued Product

Remoxipride hydrochloride (Cat. No. 0916) has been withdrawn from sale for commercial reasons.
Description: Selective D2-like antagonist
Chemical Name: (S)-(-)-3-Bromo-N-[(1-ethyl-2-pyrrolidinylmethyl]2,6-dimethoxybenzamide hydrochloride
Citations (1)
Literature (2)

Biological Activity for Remoxipride hydrochloride

Remoxipride hydrochloride is a dopamine D2 receptor antagonist showing selectivity over D3 and D4 receptors (Ki values are ~ 300, ~ 1600, and ~ 2800 nM for D2, D3 and D4 receptors respectively). Exhibits antipsychotic activity in vivo with no extrapyramidal side effects. 50-fold more potent than sulpiride in antagonising the effects of apomorphine in the rat.

Technical Data for Remoxipride hydrochloride

M. Wt 407.73
Formula C16H23BrN2O3.HCl
Storage Store at RT
CAS Number 73220-03-8
PubChem ID 15565709
Smiles BrC1=CC=C(OC)C(C(NC[C@@]2(CCCN2CC)[H])=O)=C1OC.Cl

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

Product Datasheets for Remoxipride hydrochloride

Certificate of Analysis / Product Datasheet
Select another batch:

References for Remoxipride hydrochloride

References are publications that support the biological activity of the product.

Ahlenius et al (1997) In vivo effects of remoxipride and aromatic ring metabolites in the rat. J.Pharmacol.Exp.Ther. 283 1356 PMID: 9400011

Mohell et al (1993) Binding characteristics of remoxipride and its metabolites to DA D2 and D3 receptors. Eur.J.Pharmacol. 238 121 PMID: 8405075

Sedvall (1990) Development of a new antipsychotic remoxipride. Acta Psychiatr.Scand.Suppl. 358 1 PMID: 1978466

Seeman and Van Tol (1994) DA receptor pharmacology. TiPS 15 264 PMID: 7940991

View Related Products by Target

View Related Products by Product Action

View all Non-selective Dopamine Antagonists

Keywords: Remoxipride hydrochloride, Remoxipride hydrochloride supplier, selective, D2-like, antagonists, dopamine, non-selective, receptor, antagonist, dopaminergic, d2, Non-selective, Dopamine, 0916, Tocris Bioscience

1 Citation for Remoxipride hydrochloride

Citations are publications that use Tocris products. Selected citations for Remoxipride hydrochloride include:

André et al (2011) Differential electrophysiological changes in striatal output neurons in Huntington's disease. J Neurosci 31 1170 PMID: 21273402

Reviews for Remoxipride hydrochloride

There are currently no reviews for this product. Be the first to review Remoxipride hydrochloride and earn rewards!

Have you used Remoxipride hydrochloride?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.

Dopamine Receptors Scientific Review

Dopamine Receptors Scientific Review

Written by Phillip Strange and revised by Kim Neve in 2013, this review summarizes the history of the dopamine receptors and provides an overview of individual receptor subtype properties, their distribution and identifies ligands which act at each receptor subtype. Compounds available from Tocris are listed.

Parkinson's Disease Poster

Parkinson's Disease Poster

Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.